Page 6 - Pharma Industry

Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%

Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients

Pharma industry has risen to occasion during the pandemic: Satish Reddy

He said the crisis itself presented the industry with several opportunities and allowed us to think differently

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

Govts or manufacturers, who is on the hook if Covid-19 vaccines go wrong?

Policy makers in developing nations may not have a choice but to take what they can get - easily, cheaply and quickly

Sun Pharma starts phase 2 trial for drug to treat plaque psoriasis

Sun Pharma on Monday said it has initiated Phase 2 clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis.

Gland Pharma's growth trajectory to remain elevated in medium term

Margin expansion to support profits, clean regulatory track record to help sustain growth journey

Phase 3 trial of Novavax investigational coronavirus vaccine begins

The Phase 3 trial of another investigational Covid-19 vaccine developed by biotechnology company Novavax, has started enrolling adult volunteers, the US National Institutes of Health (NIH) announced

India to play key role in vaccine rollout around the world: Pharma industry

The world is looking at India as a beacon of hope to manufacture and supply the huge number of vaccines needed to tackle the pandemic

Scientists find new class of drugs that may treat blood, bone marrow cancer

A group of scientists in the US, including an Indian-American from the prestigious Cleveland Clinic, have identified a potential new class of drugs that may prove effective in treating certain common types of blood and bone marrow cancers. First published in the latest edition of Blood Cancer Discovery, the decade long research which reports that a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations, was carried out by Jaroslaw Maciejewski and his collaborator Babal Kant Jha from the Cleveland Clinic Department of Translational Hematology & Oncology Research. Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells. One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Maciejewski and Jha. In preclinical models, we found that a synthetic molecule called TETi76 was ..

Dr Reddy's seeks nod from Canada for Favipiravir pills for Covid treatment

Dr Reddy's Canada has filed an application on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 adult patients

Glenmark Pharma gets tentative nod from USFDA for blood thinning drug

Drug major Glenmark Pharma on Monday said it has received tentative approval from the US health regulator for anticoagulant Dabigatran Etexilate capsules

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Aurobindo Pharma gets USFDA approval for drug used to sedate patients

Drug major Aurobindo Pharma said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients

Amazon may invest $100 million in India's Apollo Pharmacy: Report

Amazon is considering a nearly $100 million investment in India's Apollo Pharmacy, facing up to Reliance Industries and Tata Group in the country's fast-growing drug market, a report said

November domestic pharma sales grow just 1% after strong show last month

Oct growth rate was 9.6%; Most big corporates saw volumes drop in November

Moderna to supply up to 125 mn Covid vaccine doses globally in 1st quarter

Moderna said it expects to have between 100 million and 125 million doses of its experimental Covid-19 vaccine available globally in the first quarter of 2021

Alembic Pharma gets USFDA nod for pills to treat salt, water retention

Alembic Pharmaceuticals said it received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease

Strides Pharma Science gets USFDA nod for generic Prednisone tablets

Strides Pharma Science Ltd on Monday said it has received approval from the US health regulator for its generic version of Prednisone tablets, prescribed for a variety of conditions, including allergies, respiratory illness and arthritis. The approval for Prednisone tablets by the US Food & Drug Administration (USFDA) granted to the company's step-down wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, is for multiple strengths of 2.5 mg and 5 mg, Strides Pharma Science said in a regulatory filing. The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Deltasone tablets, 2.5 mg and 5 mg, of Pharmacia and Upjohn Co, it added. Citing IQVIA MAT September 2020 data, the company said the US market for Prednisone Tablets USP, 2.5 mg and 5 mg is approximately USD 30 million. "The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma Inc in the US market," it ...

We can stop Covid-19: Moderna vaccine success gives world more hope

Moderna's experimental vaccine is 94.5% effective in preventing Covid-19 based on data from a late-stage trial, it said, becoming the second US drugmaker to report results that far exceed expectations

Govt to launch PLI schemes for 10 sectors in 45 days. Is it overambitious?

By setting a deadline of 45 days for extending the scheme to 10 industries, the government may be ignoring the critical demands of the targeted industries